Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P48357: Variant p.Cys604Gly

Leptin receptor
Gene: LEPR
Feedback?
Variant information Variant position: help 604 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help US The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Cysteine (C) to Glycine (G) at position 604 (C604G, p.Cys604Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (C) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In LEPRD; uncertain significance. Any additional useful information about the variant.


Sequence information Variant position: help 604 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1165 The length of the canonical sequence.
Location on the sequence: help KMYEVYDAKSKSVSLPVPDL C AVYAVQVRCKRLDGLGYWSN The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         KMYEVYDAKSKSVSLPVPDLCAVYAVQVRCKRLDGLGYWSN

Rhesus macaque                KMYDVYDAKSKSVSLPVPDFCAVYAVQVRCKRSDGLGLWSN

Mouse                         KTHEVFDAKSKSASLLVSDLCAVYVVQVRCRRLDGLGYWSN

Rat                           KTHEVFDAKSKSASLPVSDLCAVYVVQVRCRRLDGLGYWSN

Pig                           KIYEVYDTKLKSTSLPVPDLCAVYAVQVRCKRLDGLGYWSN

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 22 – 1165 Leptin receptor
Topological domain 22 – 839 Extracellular
Domain 539 – 634 Fibronectin type-III 2
Glycosylation 624 – 624 N-linked (GlcNAc...) asparagine



Literature citations
Seven novel deleterious LEPR mutations found in early-onset obesity: a DeltaExon6-8 shared by subjects from Reunion Island, France, suggests a founder effect.
Huvenne H.; Le Beyec J.; Pepin D.; Alili R.; Kherchiche P.P.; Jeannic E.; Frelut M.L.; Lacorte J.M.; Nicolino M.; Viard A.; Laville M.; Ledoux S.; Tounian P.; Poitou C.; Dubern B.; Clement K.;
J. Clin. Endocrinol. Metab. 100:E757-E766(2015)
Cited for: VARIANTS LEPRD HIS-422; GLY-604 AND PRO-786;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.